Humana Inc. (HUM)

Humana's stock price has fluctuated over the past six months. Between January 13, 2025, and January 9, 2026, the share price declined by 3.66%. Over the last 12 months, the stock's price decreased by 4.70%, though it saw a 2.05% increase in the past month. In October 2024, Humana's shares plunged after CMS announced a downgrade in the quality rating of one of its Medicare Advantage plans, which led Jefferies to cut its rating on Humana. Earlier in January 2025, the stock also declined due to company warnings about higher medical costs and government regulations impacting profits.

Historical data suggests some seasonality in Humana Inc. (HUM) stock performance. Buying Humana stock in April has shown the highest probability of a positive return (76.92%), while March has historically had the lowest probability of a positive return (16.67%).

Humana Inc. is an American for-profit health and well-being company headquartered in Louisville, Kentucky, operating in the managed healthcare and insurance industries. It offers medical and supplemental benefit plans, focusing on Medicare Advantage and prescription drug plans. Humana provides specialty benefits like dental and vision insurance. The company has Medicaid and long-term support service contracts with states, including for dual-eligible beneficiaries. Humana offers commercial fully-insured medical and specialty health insurance for employer groups. It provides military services, including the TRICARE T2017 East Region contract. Through its CenterWell segment, Humana delivers healthcare services, including pharmacy solutions, provider services, and home solutions like home health and hospice.

Humana serves a geographically diverse membership base across all 50 states in the United States and is headquartered in Louisville, Kentucky. Humana has actively expanded its presence, for instance, increasing its Medicare Advantage plan offerings in New Jersey to cover approximately 95% of the state.

Humana has maintained a strong brand reputation in several areas. As of October 2024, Humana ranked No. 1 among health insurers for customer experience (CX) by Forrester for the fourth consecutive year. In August 2024, PEOPLE magazine recognized Humana as one of the "100 Companies That Care". U.S. News & World Report recognized Humana as the 2024 Best Insurance Company for Medicare Advantage in three categories. However, the downgrade of a significant Medicare Advantage plan's quality rating by CMS in October 2024 negatively impacted Humana's reputation and stock performance.

Humana's ownership is predominantly institutional, with institutional investors holding over 92% of the company's stock. Key institutional shareholders include Vanguard Group Inc., BlackRock, Inc., Dodge & Cox, State Street Corp, JPMorgan Chase & Co, Pzena Investment Management Llc, and Eagle Capital Management Llc. David A. Jones Sr. is the largest individual shareholder, owning 0.89% of the company.